News
A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...
Mount Gilead State Park provides beautiful natural settings for walking off those pastry calories, with trails that showcase Ohio’s landscape through the seasons. The town itself contains charming ...
Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...
Mount Gilead State Park provides beautiful natural settings for walking off those donut calories, with trails that showcase ...
If you haven’t heard of The Handmaid’s Tale by now, you’ve probably been living under a rock or maybe in your own personal Gilead.
Shares of Gilead Sciences Inc. slipped 4.28% to $109.64 Friday, on what proved to be an all-around dismal trading session for ...
Jessie Avalene Barrick was born November 22, 1925 in Cardington, Ohio to Walter and Lulu Sautter. After a few years in ...
This was the stock's second consecutive day of gains.
We came across a bullish thesis on Gilead Sciences, Inc. on Dividend Talks’s Substack. In this article, we will summarize the ...
Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).
Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.
Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results